Novartis takes 10 pct in dental implant firm Thommen
ZURICH, May 14 (Reuters) - Novartis AG (NOVN.VX) holds a 10 percent stake in privately owned Swiss dental implant maker Thommen Medical, Thommen said on Monday.
Novartis is expected to increase its stake to 20 percent in late summer, but Thommen's two current main shareholders will continue to hold a "clear majority" of shares, the company said, without identifying them.
"Novartis is a strategic partner for us," Thommen Chief Executive Andreas Stutz said in a statement. Novartis, which confirmed it had a 10 percent stake, also has a representative on the board of Thommen, which was set up in 2001 and does not disclose its sales.
((Reporting by Sam Cage
editing by Jane Baird
Email: zurich.newsroom@reuters.com
Reuters Messaging:
sam.cage.reuters.com@reuters.net
Telephone: +41 (0) 44 631 7457)) Keywords: NOVARTIS THOMMEN/
(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nL14724446
